Bionano Genomics
Bionano Genomics Q1 Revenues Drop 26 Percent
The firm booked $6.5 million in revenues during Q1, the first full quarter after shifting its strategy to only focus on existing core customers.
Bionano Genomics Posts 24 Percent Drop in Q4 Revenues
This year, the company hopes to install 15 to 20 new optical genome mapping systems at existing customer sites that are expanding capacity as well as at new sites.
In Brief This Week: Bionano Genomics, IntelliGenome, Pacific Biosciences, Revvity, Angle
News items for the week of Jan. 20, 2025.
Preliminary Earnings Roundup: Oxford Nanopore, 10x Genomics, Bionano Genomics, Standard BioTools
Several tools firms reported fourth quarter and full-year 2024 revenues and other business updates ahead of the annual JP Morgan Healthcare Conference this week.
Bionano Genomics Restructures Debt, Initiates $10M Direct Offering
The optical genome mapping firm deferred its December 2024 amortization payment and reduced payments in the first half of 2025 to improve its cash position, and separately announced a $10 million direct stock offering.
May 28, 2024
Bionano Genomics Raises $17.9M in Debt Financing
May 8, 2024
Bionano Genomics Q1 Revenues up 18 Percent
Jan 17, 2024